To rule out the possibility of contamination from liver cells and normal mammary epithelial cells, the patient-derived organoids were validated as HER2-overexpression breast cancer organoids before experiments (Supplementary Fig. 8f). This evidence concerns the gene ERBB2 and breast carcinoma.